전체 프로그램

ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved170 programs
ADCCurated CoreFDAstaleRochevedotin, rituximab, cycloph…Phase 3

Polatuzumab Vedotin (Polatuzumab Vedotin)

Large B-Cell Lymphoma · FRα

#FR#ADC#Phase3#FDA-approved#BioJungboMoa-pick+5
Trials 91Status Recruiting
ADCCurated CoreFDAAbbVieDM4 (maytansinoid, tubulin …Approved

mirvetuximab soravtansine (Elahere, IMGN853, mirvetuximab-soravtansine-gynx)

FRα-positive platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer · FRα (folate receptor alpha)

#FRfolatereceptoralpha#ADC#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 32Status Approved
AntibodyLimited DatastaleRochePhase 3

Mabthera (Mabthera)

Relapsed Diffuse Large B-cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma · FRα

#FR#Antibody#Phase3#Popular#monoclonal-antibody+4
Trials 129Status Active
AntibodyCurated CorestaleBristol Myers SquibbPhase 2

Relatlimab (Relatlimab)

Various Advanced Cancer · FRα

#FR#Antibody#Phase2#BioJungboMoa-pick#Popular+4
Trials 74Status Recruiting
CGTStandard DatabasestaleImcyse SAPhase 2

Multi-epitope (ME, Multi-epitope, Multi-epitope (ME) T-cell Receptor Alternate Reading Frame Protein (TARP) vaccine)

Prostatic Neoplasms; Neoplasms of Prostate · FRα

#FR#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 62Status Active
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 1

chimeric antigen receptor T cell (chimeric antigen receptor T cell)

Pancreatic Cancer; CAR · FRα

#FR#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 62Status Active
CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

chimeric antigen receptor T cell treatment (chimeric antigen receptor T cell treatment)

T Cell Lymphoma; T-cell Leukemia · FRα

#FR#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 62Status Active
CGTLimited DatastaleAbbottPhase 1

valproic acid (valproic acid)

Advanced Malignant Neoplasm; Castleman Disease · FRα

#FR#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 62Status Discontinued
CGTLimited DatastaleHebei Senlang Biotechnology Inc…Phase 2

Autologous CAR-T cells (Autologous CAR-T cells)

Leukemia; Lymphoma · FRα

#FR#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 61Status Active
CGTStandard DatabasestaleNational Cancer Institute (NCI)Phase 2

Multi-epitope (ME, Multi-epitope, Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine)

Prostatic Neoplasms; Prostate Cancer · FRα

#FR#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 61Status Discontinued
CGTStandard DatabasestaleMedigene AGPhase 2

Lymphodepletion (Lymphodepletion)

Epithelial Ovarian Cancer; Gastro-esophageal Junction Cancer · FRα

#FR#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 60Status Discontinued
ADCStandard DatabasestaleFavrillederuxtecan for metastatic b…Phase 2

Antibody-Drug Conjugate Therapy (Antibody-Drug Conjugate Therapy)

Metastatic Bladder Urothelial Carcinoma; Metastatic Renal Pelvis and Ureter Urothelial Carcinoma · FRα

#FR#ADC#Phase2#Popular#antibody-drug-conjugate+5
Trials 58Status Recruiting
CGTLimited DatastaleMarzieh EbrahimiPhase 1

Allogenic NK cells infusion (Allogenic NK cells infusion)

Neuroblastoma, Recurrent, Refractory; Neuroblastoma (NB) · FRα

#FR#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 56Status Recruiting
AntibodyCurated CorestalePfizerApproved

Elranatamab (Elranatamab)

Multiple Myeloma · FRα

#FR#Antibody#Approved#BioJungboMoa-pick#Popular+4
Trials 54Status Recruiting
CGTLimited DatastaleInternational Brain Research Fo…Phase 2

Quercetin (Quercetin)

Recurrent Multiple Myeloma; Refractory Multiple Myeloma · FRα

#FR#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 54Status Recruiting
CGTStandard DatabasestaleKiteApproved

axicabtagene ciloleucel (Yescarta, axi-cel)

DLBCL; Diffuse Large B Cell Lymphoma · FRα

#FR#CGT#Approved#Popular#cell-gene-therapy+5
Trials 53Status Recruiting
AntibodyLimited DatastalePfizerPhase 2

PF-06863135 (Elranatamab, Elranatamab (PF-06863135))

Multiple Myeloma · FRα

#FR#Antibody#Phase2#Popular#monoclonal-antibody+3
Trials 51Status Active
AntibodyCurated CorestaleEpizyme, Inc.Phase 3

Mosunetuzumab (Mosunetuzumab)

Relapsed Hematologic Malignancy; Refractory Hematologic Malignancy · FRα

#FR#Antibody#Phase3#BioJungboMoa-pick#monoclonal-antibody+4
Trials 49Status Recruiting
CGTLimited DatastaleHistograft Co., Ltd.Preclinical

"Histograft", a bone substitute based on octacalcium phosphate (OCP, "Histograft", a bone substitute based on octacalcium phosphate, "Histograft", a bone substitute based on octacalcium phosphate (OCP) and plasmid DNA encoding VEGFA gene)

Non Union Fracture; Non-Union of Ankle Joint Without Infection · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+5
Trials 45Status Active
CGTLimited DatastaleSecuraBioPhase 1

Duvelisib (Duvelisib)

Recurrent Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 45Status Active

1 / 9 pages

← PreviousNext →